Search Within

Subhiksha Nandakumar

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (19)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. GSK Faculty (47)
  2. Human Oncology and Pathogenesis Program (47)
  3. Department of Medicine (35)
  4. Department of Pathology and Laboratory Medicine (35)
  5. Solid Tumor Oncology Division (35)
  6. Epidemiology and Biostatistics (34)

More Groups

People
  1. Nikolaus Schultz (30)
  2. Michael Berger (22)
  3. David Solit (20)
  4. Ingo Mellinghoff (17)
  5. Angela Brannon (15)
  6. Marc Ladanyi (15)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (7)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Neuro-Oncology (7)
  3. Cancer Research (6)
  4. Journal of Clinical Oncology (4)
  5. Cancer Discovery (2)
  6. European Urology (2)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Oxford University Press (8)
  3. Nature Publishing Group (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting
    Journal Article

    Rajanala, S. H.; Ghale, R.; Nandakumar, S.; Chadalavada, K.; Lee, G. S. M.; Stopsack, K. H.; Chen, Y.; Nanjangud, G. J.; Chakraborty, G.; Kantoff, P. W.
    PLoS ONE (2024)

    Fulltext@MSK | Save
  • Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series
    Journal Article

    Anselmino, N.; Labanca, E.; Shepherd, P. D. A.; Dong, J.; Yang, J.; Song, X.; Nandakumar, S.; Kundra, R.; Lee, C.; Schultz, N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response
    Correspondence

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Malani, R.; Panageas, K. S.; Mellinghoff, I. K.; Bale, T. A.; Young, R. J.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Journal Article

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Thomas, T. M.; Nicklin, P. J.; Choi, Y.; Skakodub, A.; Malani, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Droplet digital PCR enhances detection of hotspot mutations in circulating tumor DNA from cerebrospinal fluid of patients with high-grade glioma
    Meeting Abstract

    Tartaro, M.; Nandakumar, S.; Hertz, C. A.; Holle, B.; Hill, K.; Lapshina, M.; Farina, A.; Arcila, M.; Miller, A.; Mellinghoff, I.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Modeling reversible tumorigenesis in cerebral organoids
    Meeting Abstract

    Graham, M.; Codega, P.; Campos, C.; Nandakumar, S.; Rosenblum, M.; Antonescu, C.; Grogan, M.; Benhamida, J.; Bale, T.; von Deimling, A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save